Bioluminescence Ventures Reveals Partners and Investment Management Team

SAN FRANCISCO–(BUSINESS WIRE)–Bioluminescence Ventures (“BLV”), a biotech venture firm investing in next-generation medicines, today revealed its initial team of Partners, whose collective experience and expertise spans preclinical research, translational science, clinical development, medical affairs, regulatory, commercial strategy, business development, and strategic investment banking functions across therapeutic areas. BLV recently emerged…
Click here to view original post

Advertisement — Advertise with Biotech Networks